510(k) K821347
K821347 is an FDA 510(k) premarket notification submitted by Bioclinical Corp. for the device "BIO-MAG THEOPHYLLINE (125I) RADIOIMMUN.". The FDA issued a decision of Substantially Equivalent on May 28, 1982. The device falls under product code LCA (Radioimmunoassay, Theophylline), a Class II device regulated under 21 CFR 862.3880.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 28, 1982
- Date Received
- May 5, 1982
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Theophylline
- Device Class
- Class II
- Regulation Number
- 862.3880
- Review Panel
- TX
- Submission Type